Ligand-based drug design combines AI and QSAR modeling to prioritize drug candidates, minimizing preclinical failures and ...
Konstanz molecular biologist Elke Deuerling has been admitted to the German National Academy of Sciences, the "Leopoldina".
Peptide therapeutics require tailored ADME strategies to address stability, supporting more effective and reliable drug ...